[96a5a0]: / output / allTrials / identified / NCT01102231_identified.json

Download this file

250 lines (250 with data), 9.8 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
{
"info": {
"nct_id": "NCT01102231",
"official_title": "Phase II Study of Pemetrexed + Cetuximab + Cisplatin With Concurrent Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC)",
"inclusion_criteria": "* non-squamous stage III non-small cell lung cancer\n* measurable disease (RECIST 1.1)\n* ECOG performance status 0-1\n* normal organ and marrow function\nHealthy volunteers allowed\nMust have minimum age of 18 Years\nMust have maximum age of 70 Years",
"exclusion_criteria": "* prior chest radiation therapy\n* history of any cancer other than NSCLC (except non-melanoma skin cancer or carcinoma in situ of the cervix) within the last five years.\n* Prior therapy with known specific inhibitors of the EGFR.\n* history of severe allergic reaction to prior therapy with monoclonal antibodies",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* non-squamous stage III non-small cell lung cancer",
"criterions": [
{
"exact_snippets": "non-squamous",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "specificity",
"expected_value": "non-squamous"
}
]
},
{
"exact_snippets": "stage III",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "III"
}
]
},
{
"exact_snippets": "non-small cell lung cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "specificity",
"expected_value": "non-small cell lung cancer"
}
]
}
]
},
{
"line": "* measurable disease (RECIST 1.1)",
"criterions": [
{
"exact_snippets": "measurable disease (RECIST 1.1)",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "criteria",
"expected_value": "RECIST 1.1"
}
]
}
]
},
{
"line": "* ECOG performance status 0-1",
"criterions": [
{
"exact_snippets": "ECOG performance status 0-1",
"criterion": "ECOG performance status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* normal organ and marrow function",
"criterions": [
{
"exact_snippets": "normal organ",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "normal ... marrow function",
"criterion": "marrow function",
"requirements": [
{
"requirement_type": "functionality",
"expected_value": "normal"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 70 Years",
"criterions": [
{
"exact_snippets": "maximum age of 70 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 70,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* prior chest radiation therapy",
"criterions": [
{
"exact_snippets": "prior chest radiation therapy",
"criterion": "chest radiation therapy",
"requirements": [
{
"requirement_type": "prior",
"expected_value": true
}
]
}
]
},
{
"line": "* history of any cancer other than NSCLC (except non-melanoma skin cancer or carcinoma in situ of the cervix) within the last five years.",
"criterions": [
{
"exact_snippets": "history of any cancer other than NSCLC",
"criterion": "history of cancer",
"requirements": [
{
"requirement_type": "type",
"expected_value": "any cancer other than NSCLC"
},
{
"requirement_type": "time frame",
"expected_value": "within the last five years"
}
]
},
{
"exact_snippets": "except non-melanoma skin cancer or carcinoma in situ of the cervix",
"criterion": "cancer type exception",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"non-melanoma skin cancer",
"carcinoma in situ of the cervix"
]
}
]
}
]
},
{
"line": "* Prior therapy with known specific inhibitors of the EGFR.",
"criterions": [
{
"exact_snippets": "Prior therapy with known specific inhibitors of the EGFR",
"criterion": "prior therapy with EGFR inhibitors",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* history of severe allergic reaction to prior therapy with monoclonal antibodies",
"criterions": [
{
"exact_snippets": "history of severe allergic reaction to prior therapy with monoclonal antibodies",
"criterion": "severe allergic reaction to monoclonal antibodies",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}